Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of mechanistic and pharmacokinetic data

Fundamental and Applied Toxicology

Volumn 37, Issue 1, 1997, Pages 16-36

  Page, N P ^a   Singh, D V ^b   Farland, W ^b   Goodman, J I ^c   Conolly, R B ^d   Andersen, M E ^e   Clewell, H J ^f   Frederick, C B ^g   Yamasaki, H ^h   Lucier, G ⁱ  

^a ToxaChemica International   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^e ICF Kaiser Engineers Inc   (United States)

^f ICF Kaiser International   (United States)

^g ROHM AND HAAS COMPANY   (United States)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHLOROFORM; TRICHLOROETHYLENE;

CANCER; CANCER RISK; CARCINOGENESIS; CONFERENCE PAPER; HUMAN; NONHUMAN; RISK ASSESSMENT;

EID: 26844458434     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2305     Document Type: Conference Paper

References (56)

1. Allen B. D., Fisher J. W. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13:1993;71-86.5.
2. Ames B. N., Gold L. S. Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA. 87:1990;7772-7776.
3. Andersen M. E., Mills J. J., Jirtle R. L., Greenlee W. F. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology. 120:1995;223-237.
4. Birner G., Vamvakas S., Dekant W., Henschler D. Nephrotoxic and genotoxicNSL. Environ. Health Perspect. 99:1993;281-284.
5. Bucher J. R., Portier C. J., Goodman J. I., Faustman E. M., Lucier G. W. National Toxicology Program studies: Principles of dose selection and applications to mechanistic based risk assessment. Fundam. Appl. Toxicol. 31:1966;1-8.
6. Bull R. J., Templin M., Larson J. L., Stevens D. K. The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene. Toxicol. Lett. 68:1993;203-211.
7. Butterworth B. E., Conolly R. B., Morgan K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessment. Cancer Lett. 93:1995;129-146.
8. California Environmental Protection Agency, 1996, Public review draft report of the Risk Assessment Advisory Committee: A Review of the California Environmental Protection Agency's Risk Assessment Practices, Policies, and Guidelines.
9. Clewell H. J., Gentry P. R., Gearhart J. M., Allen B. C., Andersen M. E. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere. 31:1995;2561-2578.
10. Cohen S. M., Ellwein L. B. Risk assessment based on high-dose animal exposure experiments. Chem. Res. Toxicol. 5:1992;742-748.
11. Commission on Risk Assessment and Risk Management, 1996, Draft report for public review and comment: "Risk Assessment and Risk Management in Regulatory Decision-Making"
12. Conolly R. B., Butterworth B. E. Biologically based dose response model for hepatic toxicity: A mechanistically based replacement for traditional estimates of noncancer risk. Toxicol. Lett. 82/83:1995;901-906.
13. Corley R. A., Mendrala A. L., Smith F. A., Staats D. A., Gargas M. L., Conolly R. B., Andersen M. E., Reitz R. H. Development of a physiologically-based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103:1990;512-527.
14. Counts J. L., Goodman J. I. Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion. Mol. Carcinogen. 11:1994;185-188.
15. Counts J. L., Goodman J. I. Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: Dose influences mechanism. Regul. Toxicol. Pharmacol. 21:1995a;418-421.
16. Counts J. L., Goodman J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell. 83:1995b;13-15.
17. Counts J. L., Goodman J. I. Hypomethylation of DNA: A nongenotoxic mechanism involved in tumor promotion. Toxicol. Lett. 82/83:1995c;663-672.
18. Counts J. L., Goodman J. I. Hypomethylation of DNA: A possible epigenetic mechanism involved in tumor promotion. Growth Factors and Tumor Promotion: Implications for Risk Assessment. 1995d;Wiley-Liss, New York. p. 81-101.
19. Counts J. L., Sarmiento J .I., Harbison M. L., Downing J. C., McClain R. M., Goodman J. I. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine deficient diet administration. Carcinogenesis. 17:1996;1251-1257.
20. Davidson I. W. F., Beliles R. P. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23:1991;493-495.
21. Eschenbrenner A. B., Miller E. Induction of hepatomas in mice by repeated oral administration of chloroform with observations on sex differences. J. Natl. Cancer Inst. 5:1945;251-255.
22. Goodman J. I. The carcinogen bioassay in perspective: A requirement for incorporation of biological information. In Vitro Toxicol. 3:1990;1-7.
23. Goodman J. I. A rational approach to risk assessment requires the use of biological information: An analysis of the National Toxicology Program (NTP) final report of the advisory review by the NTP Board of Scientific Counselors. Reg. Toxicol. Pharmacol. 19:1994;51-59.
24. Goodman J. I. An analysis of the National Toxicology Program's (NTP) technical report (NTP TR 421) on the toxicology and carcinogenesis studies of talc. Regul. Toxicol. Pharmacol. 21:1995;244-249.
25. Haseman J. K., Lockhart A. The relationship between use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity. Fundam. Appl. Toxicol. 22:1994;382-391.
26. Heywood R., Sortwell R. J., Noel P. R. B., Street A. E., Prentice D. E., Roe F. J. C., Wadsworth P. F., Worden A. N., Van Abbe N. J. Safety evaluation of toothpaste containing chloroform. III. Long-term study in beagle dogs. J. Environ. Pathol. Toxicol. 2:1979;835-851.
27. Jorgenson T. A., Meierhenry E. F., Rushbrook C. J., Bull R. J., Robinson M. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5:1985;760-769.
28. Larson J. L., Sprankle C. S., Butterworth B. E. Lack of chloroform-induced DNA repairin vitroin vivo. Environ. Mol. Mutagen. 23:1994a;132-136.
29. Larson J. L., Wolf D. C., Butterworth B. E. Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage. Fundam. Appl. Toxicol. 23:1994b;537-543.
30. Larson J. L., Wolf D. C., Butterworth B. E. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs. ad libitum in drinking water. Fundam. Appl. Toxicol. 22:1994c;90-102.
31. Larson J. L., Wolf D. C., Butterworth B. E. Induced regenerative cell proliferation in livers and kidneys of male F344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology. 95:1995a;73-86.
32. Larson J. L., Wolf D. C., Mery S., Morgan K. T., Butterworth B. E. Toxicity and cell proliferation in the liver, kidneys and nasal passages of female F344 rats, induced by chloroform administered by gavage. Food Chem. Toxicol. 33:1995b;443-456.
33. McClain R. M. Mechanistic considerations in the regulation and classification of chemical carcinogens. Kotsonis F. N., Mackey M., Hjelle J. Nutritional Toxicology. 1994;273-304 Raven Press, NY.
34. Melnick R. L. Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6:1992;2698-2706.
35. Muller G., Spassovski M., Henschler D. Metabolism of trichloroethylene in man. III. Interaction of trichloroethylene and ethanol. Arch. Toxicol. 33:1975;173.
36. National Cancer Institute (NCI), 1976, Carcinogenesis Bioassay of Chloroform.
37. National Research Council (NRC), 1983, Risk Assessment in the Federal Government: Managing the Process, National Academy Press, Washington, DC.
38. National Research Council (NRC), 1994, Science and Judgment in Risk Assessment. Committee on Risk Assessment of Hazardous Air Pollutants, National Research Council, National Academy Press, Washington, DC.
39. Odum J., Foster J. R., Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem-Biol. Interact. 83:1992;135-153.
40. Pohl L. Biochemical toxicology of chloroform. Hodgson, Bend, Philpot. Reviews in Biochemical Toxicology. 1979;79-107 Elsevier, New York.
41. Ray J. S., Harbison M. L., McClain R. M., Goodman J. I. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. Mol. Carcinogen. 9:1994;155-166.
42. Reitz R. H., Mendrala A. L., Guengerich F. P. In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97:1989;230-246.
43. Rosenthal S. L. A review of the mutagenicity of chloroform. Environ. Mol. Mutagen. 10:1987;211-226.
44. R. J. Scheuplein, 1995, The use of biological data in addition to the carcinogen bioassay in quantitative risk assessment, Growth Factors and Tumor Promotion: Implications for Risk Assessment, R. M. McClainT. J. SlagaR. A. LeBoeufH. C. Pitot, 347, 358, Wiley, New York.
45. U.S. EPA, 1983, Health Assessment Document for Trichloroethylene: EPA/600/8-82-006B, U. S. Environmental Protection Agency, Washington, DC.
46. U.S. EPA, 1985, Health Assessment Document for Trichloroethylene: Final Report, EPA/600/8-82/006F, U. S. Environmental Protection Agency, Washington, DC.
47. U.S. EPA, 1986, Guidelines for Carcinogen Risk Assessment: EPA/600/8-82/006F, U. S. Environmental Protection Agency, Washington, DC.
48. U.S. EPA, 1987, Addendum to the Health Assessment Document for Trichloroethylene: Updated Carcinogenicity Assessment for Trichloroethylene, EPA/600/8-82/006FA, U. S. Environmental Protection Agency, Washington, DC.
49. U.S. EPA, 1989a, Workshop on EPA guidelines for Carcinogen Risk Assessment, EPA/625/3-89-015, U. S. Environmental Protection Agency, Washington, DC.
50. U.S. EPA, 1989b, Workshop on EPA Guidelines for Carcinogen Risk Assessment: Use of Human Evidence, EPA/625/3-90-017, U. S. Environmental Protection Agency, Washington, DC.
51. U.S. EPA, 1992, Safeguarding the Future: Credible Science, Credible Decisions, EPA/600/9-91/050, U. S. Environmental Protection Agency, Washington, DC.
52. U.S. EPA, 1995, Chloroform Listing on the Integrated Risk Information System (IRIS) Database, U. S. Environmental Protection Agency, Washington, DC.
53. Fed. Reg. 61:1996;17960-18011.
54. Vorce R. L., Goodman J. I. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. J. Toxicol. Environ. Health. 34:1991;367-384.
55. Wallace C. J. Hepatitis and nephrosis due to cough syrup containing chloroform. California Med. 73:1950;442.
56. Williams G. M., Whysner J. Mechanistic considerations in risk assessment for epigenetic tumor-promoting carcinogens. McClain R. M., Slaga T. J., LeBoeuf R. A., Pitot H. C. Receptor-Mediated Biological Processes: Implications for Evaluating Carcinogenesis. 1995;369-384 Wiley, New York.